Guidance on shingles vaccine (Zostavax®): patient group direction (PGD) template

Public Health England has published a patient group direction (PGD) template is to support the administration of shingles (herpes zoster, live) vaccine in accordance with the national shingles (herpes zoster) immunisation programme.

Zostavax PGD v10.00 is valid from 1 September 2021 to 31 August 2023.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy or procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.

A PGD template for Shingrix® is available to download.